JP Morgan Chase’s Oxford Immunotec Global OXFD Stock Holding History
Bought
Maintained
Sold
Other funds holding OXFD
ECM
JP Morgan Chase's OXFD Position: Q4 2020 in Review
JP Morgan Chase sold out of Oxford Immunotec Global (OXFD) in Q4 2020, closing a stake of 8,231 shares — an estimated $97K sold.
JP Morgan Chase first reported a position in OXFD in Q4 2016 and held it in 14 quarters. The position peaked at $1.92M in Q4 2019. 60 funds tracked by Wall St. Rank hold OXFD as of Q4 2020.
- JP Morgan Chase reported no remaining Oxford Immunotec Global position as of Q4 2020 after selling out during the quarter.
- JP Morgan Chase sold 8,231 Oxford Immunotec Global shares in Q4 2020, an estimated $97K.
- JP Morgan Chase first reported a position in Oxford Immunotec Global in Q4 2016 and held it in 14 quarters.
- JP Morgan Chase's Oxford Immunotec Global position peaked at $1.92M in Q4 2019.
- 60 funds tracked by Wall St. Rank held Oxford Immunotec Global as of Q4 2020.
Based on JP Morgan Chase's 13F filing for Q4 2020, filed 11 Feb 2021.